Singapore: Japan-headquartered Astellas Pharma and Ambit Biosciences have initiated the phase IIb open-label clinical tr...
Sample preparation is a daily function in any life science research or drug discovery lab and pipetting is a fundamental...
Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain...
Singapore: Boehringer Ingelheim has submitted a marketing authorization application to the European Medicines Agency (EM...
Singapore: SFJ Pharmaceuticals, primarily focused on funding and executing phase III studies of drugs, has entered into ...
Singapore: Bristol-Myers Squibb has discontinued the development of BMS-986094 (formerly known as INX-189), a nucleotide...
Singapore: Bayer HealthCare has recieved US FDA approval for Adempas (riociguat) tablets for the treatment of adults wit...
Singapore: Genzyme, a Sanofi company, received a Refuse to File letter from the US FDA in response to the supplemental B...
Singapore: The National Institutes of Health (NIH) is funding $45 million for research aimed at preventing Alzheimer's ...
Singapore: Singapore's emerging company Clearbridge BioMedics plans to launch its ClearCell FX System at American Societ...
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...
Singapore: Japan-based biopharmaceutical firm, Kyowa Hakko Kirin (KHK) has setup Singapore Translational Research Labora...
Singapore: AB Sciex, a global leader in analytical technologies, has launched MasterView Software, a new software applic...
Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...
Singapore: GlaxoSmithKline's (GSK) Dermai study, a phase III, randomized, blinded, placebo-controlled Mage-A3 cancer imm...
Singapore: The Health Sciences Authority (HSA) of Singapore has approved Bayer' Stivarga, the first oral targeted therap...
Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the ec...
Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-d...
